Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Capital Expenditures (2022 - 2023)

Historic Capital Expenditures for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to $42000.0.

  • Lexeo Therapeutics' Capital Expenditures rose 6800.0% to $42000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $115000.0, marking a year-over-year change of. This contributed to the annual value of $481000.0 for FY2024, which is 31826.09% up from last year.
  • Lexeo Therapeutics' Capital Expenditures amounted to $42000.0 in Q4 2023, which was up 6800.0% from $19000.0 recorded in Q3 2023.
  • Lexeo Therapeutics' Capital Expenditures' 5-year high stood at $42000.0 during Q2 2023, with a 5-year trough of $12000.0 in Q1 2023.